Home › Health › GSK cancer drug approved by US regulators
Health

GSK cancer drug approved by US regulators

GSK cancer drug approved by US regulators
Key Points

Lung cancer treatment was at the heart of FTSE 100 group’s $10.6bn acquisition of Nuvalent

Lung cancer treatment was at the heart of FTSE 100 group’s $10.6bn acquisition of Nuvalent
GSK (ORG) US (LOCATION) Lung (PERSON) FTSE (ORG) Nuvalent (LOCATION)
Originally published by Financial Times Read original →